Table: Ono Pharm -2022/23 group results (IFRS)

ONO PHARMACEUTICAL

10/05/2023 04:00

May 10 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Mar 31, 2023    Mar 31, 2022   Mar 31, 2024      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales            447.19          361.36                                
                 (+23.8 pct)     (+16.8 pct)                             
  Sales                                           475.00                 
                                                (+6.2 pct)               
  Operating        141.96          103.20         153.00                 
                 (+37.6 pct)     (+4.9 pct)     (+7.8 pct)               
  Pretax           143.53          105.03         154.00                 
                 (+36.7 pct)     (+4.1 pct)     (+7.3 pct)               
  Net              112.72           80.52         115.00                 
                 (+40.0 pct)     (+6.8 pct)     (+2.0 pct)               
  EPS Basic      230.85 yen      162.19 yen     235.49 yen               
  EPS Diluted    230.79 yen      162.16 yen                              
  Ann Div         70.00 yen       56.00 yen      80.00 yen               
  -Q2 Div         33.00 yen       28.00 yen      40.00 yen               
  -Q4 Div         37.00 yen       28.00 yen      40.00 yen               
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T